Ophthalmology clinical trials

Explore recruiting ophthalmology clinical trials.

Recruiting ophthalmology studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ophthalmology trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A PHASE 1/2 STUDY TO ASSESS THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND EFFECTS ON CLINICAL OUTCOMES OF PEGTIBATINASE (TVT-058) ADMINISTERED SUBCUTANEOUSLY IN SUBJECTS WITH CYSTATHIONINE BETASYNTHASE-DEFICIENT HOMOCYSTINURIA (COMPOSE)

France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Comparative clinical trial of efficacy and satisfaction of 2% gel lidocaine versus tetracaine/oxybuprocaine anesthetic eye drops in patients undergoing needing techniques in ophthalmology consultations. Anesthesia in Needling with Lidocaine (ANELI)

Spain

Therapeutic use (Phase IV) EU CTIS Study details

IMVT-1401-3201: A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants with Active Thyroid Eye Disease (TED)

Italy, Poland, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants with Active Thyroid Eye Disease (TED)

Slovakia, Spain, Hungary, Germany, Belgium, Latvia

Therapeutic confirmatory (Phase III) EU CTIS Study details

HydroxyChloroquine as steroid-sparing Agent in Extra-pulmonary SARcoidosis. A multicenter, prospective, placebo-controlled, randomized trial. CAESAR

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Ophthalmology trials by city

Ophthalmology in Toronto Ophthalmology in Vancouver Ophthalmology in Montreal Ophthalmology in Calgary Ophthalmology in Edmonton Ophthalmology in Ottawa Ophthalmology in Winnipeg Ophthalmology in Quebec City Ophthalmology in Hamilton Ophthalmology in Kitchener Ophthalmology in London Ophthalmology in Halifax Ophthalmology in New York Ophthalmology in Los Angeles Ophthalmology in Chicago Ophthalmology in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease